These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21595263)

  • 21. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incretins].
    Vrbíková J; Vondra K
    Vnitr Lek; 2006 Oct; 52(10):919-25. PubMed ID: 17063804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?
    Yabe D; Seino Y; Seino Y
    J Diabetes Investig; 2018 Jan; 9(1):21-24. PubMed ID: 28746743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucotoxicity inhibits cAMP-protein kinase A-potentiated glucose-stimulated insulin secretion in pancreatic β-cells.
    Kong X; Yan D; Wu X; Guan Y; Ma X
    J Diabetes; 2015 May; 7(3):378-85. PubMed ID: 24981285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1.
    Leech CA; Chepurny OG; Holz GG
    Vitam Horm; 2010; 84():279-302. PubMed ID: 21094904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between Munc13-1 and RIM is critical for glucagon-like peptide-1 mediated rescue of exocytotic defects in Munc13-1 deficient pancreatic beta-cells.
    Kwan EP; Xie L; Sheu L; Ohtsuka T; Gaisano HY
    Diabetes; 2007 Oct; 56(10):2579-88. PubMed ID: 17639022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Theoretical Investigations into the Quantitative Mechanisms Underlying the Regulation of [cAMP]i, Membrane Excitability and [Ca(2+)]i during GLP-1 Stimulation in Pancreatic β Cells].
    Takeda Y
    Yakugaku Zasshi; 2016; 136(3):467-71. PubMed ID: 26935088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions.
    Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):550-9. PubMed ID: 19036624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary effects on incretin hormone secretion.
    Wu T; Rayner CK; Jones K; Horowitz M
    Vitam Horm; 2010; 84():81-110. PubMed ID: 21094897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Lepr
    Samad MB; Mohsin MNAB; Razu BA; Hossain MT; Mahzabeen S; Unnoor N; Muna IA; Akhter F; Kabir AU; Hannan JMA
    BMC Complement Altern Med; 2017 Aug; 17(1):395. PubMed ID: 28793909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleiotropic actions of the incretin hormones.
    McIntosh CH; Widenmaier S; Kim SJ
    Vitam Horm; 2010; 84():21-79. PubMed ID: 21094896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular glucose availability and glucagon-like peptide-1.
    Park JH; Earm YE; Song DK
    Prog Biophys Mol Biol; 2011 Nov; 107(2):286-92. PubMed ID: 21907232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of incretin hormones.
    Efendic S; Portwood N
    Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus.
    Vilsbøll T
    Dan Med Bull; 2004 Nov; 51(4):364-70. PubMed ID: 16009062
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice.
    Pathak V; Vasu S; Gault VA; Flatt PR; Irwin N
    Diabetologia; 2015 Sep; 58(9):2144-53. PubMed ID: 26048235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
    Montrose-Rafizadeh C; Egan JM; Roth J
    Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incretins, insulin secretion and Type 2 diabetes mellitus.
    Vilsbøll T; Holst JJ
    Diabetologia; 2004 Mar; 47(3):357-366. PubMed ID: 14968296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose-incretin interaction revisited.
    Ishii H; Sato Y; Takei M; Nishio S; Komatsu M
    Endocr J; 2011; 58(7):519-25. PubMed ID: 21701075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low, but physiological, concentration of GLP-1 stimulates insulin secretion independent of the cAMP-dependent protein kinase pathway.
    Shigeto M; Katsura M; Matsuda M; Ohkuma S; Kaku K
    J Pharmacol Sci; 2008 Nov; 108(3):274-9. PubMed ID: 18987435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.